Purchases and Sales Made in Q3 2023 in Immunocore Holdings PLC (IMCR)
This table provides information about the institutional ownership of Immunocore Holdings PLC (IMCR) during Q3 2023. The information is specifically focused on institutions that hold shares of Immunocore Holdings plc.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2023
Q3 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-81.6K- 37.08% |
$4.04M - $5.43M
|
138K
$3.91M
|
|
Nov 14, 2023
Q3 2023
|
Rock Springs Capital Management LP
Baltimore, MD |
SELL
|
- |
-84.7K- 2.8% |
$4.19M - $5.64M
|
2.94M
$83.2M
|
|
Nov 07, 2023
Q3 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-132K- 67.0% |
$6.54M - $8.8M
|
65.1K
$1.84M
|
|
Aug 22, 2024
Q3 2023
|
Fiera Capital Corp
Montreal, A8 |
SELL
|
- |
-196K- 22.36% |
$9.69M - $13M
|
680K
$19.2M
|
|
Nov 14, 2023
Q3 2023
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-227K- 39.44% |
$11.2M - $15.1M
|
348K
$9.84M
|
|
Nov 14, 2023
Q3 2023
|
Holocene Advisors, LP
New York, NY |
SELL
|
- |
-529K- 76.17% |
$26.2M - $35.2M
|
165K
$4.67M
|